Luxury feet is a Topical Gel in the Human Otc Drug category. It is labeled and distributed by Nutra Pharma Corporation. The primary component is Naja Naja Venom.
Product ID | 47219-342_c730bb13-e53e-c008-e053-2995a90a771b |
NDC | 47219-342 |
Product Type | Human Otc Drug |
Proprietary Name | Luxury feet |
Generic Name | Naja Naja Venom |
Dosage Form | Gel |
Route of Administration | TOPICAL |
Marketing Start Date | 2021-07-15 |
Marketing Category | UNAPPROVED HOMEOPATHIC / |
Labeler Name | Nutra Pharma Corporation |
Substance Name | NAJA NAJA VENOM |
Active Ingredient Strength | 4 [hp_X]/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-07-15 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
47219-342 | Luxury feet | NAJA NAJA VENOM |
47219-102 | COBROXIN | NAJA NAJA VENOM |
47219-104 | COBROXIN | NAJA NAJA VENOM |
64117-267 | HEADACHE DRY COUGH | NAJA NAJA VENOM |
0220-3541 | Naja tripudians | NAJA NAJA VENOM |
0220-3542 | Naja tripudians | NAJA NAJA VENOM |
0220-3543 | Naja tripudians | NAJA NAJA VENOM |
0220-3544 | Naja tripudians | NAJA NAJA VENOM |
0220-3549 | Naja tripudians | NAJA NAJA VENOM |
68428-520 | Naja tripudians | NAJA NAJA VENOM |
71919-476 | Naja tripudians | NAJA NAJA VENOM |
47219-200 | Nyloxin | NAJA NAJA VENOM |
47219-201 | NYLOXIN | NAJA NAJA VENOM |
47219-202 | NYLOXIN | NAJA NAJA VENOM |
47219-203 | NYLOXIN | NAJA NAJA VENOM |
47219-204 | NYLOXIN | NAJA NAJA VENOM |
47219-210 | Nyloxin | NAJA NAJA VENOM |
47219-250 | NYLOXIN | NAJA NAJA VENOM |
47219-251 | NYLOXIN | NAJA NAJA VENOM |
47219-252 | NYLOXIN | NAJA NAJA VENOM |
47219-253 | NYLOXIN | NAJA NAJA VENOM |
47219-300 | Nyloxin | NAJA NAJA VENOM |
47219-301 | Nyloxin | NAJA NAJA VENOM |
47219-310 | Nyloxin | NAJA NAJA VENOM |
47219-311 | Nyloxin | NAJA NAJA VENOM |
47219-341 | QPR Quick Pain Relief | Naja Naja Venom |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LUXURY FEET 90671184 not registered Live/Pending |
NUTRA PHARMA CORP. 2021-04-26 |